Triple‐negative breast cancer (TNBC) is characterized by deficiency in estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression and represents one of the most aggressive subtypes of breast cancer [1]. This evidence concerns the gene PGR and breast carcinoma.